Table 4.
Comparison between 2014 and 2017 reports | |||||
---|---|---|---|---|---|
2014 | 2017 | ||||
n/total | Percentage (95% CI) | n/total | percentage | p value | |
Reports with ILN | 108/500 | 21.6% (18.0 – 25.2%) | 101/450 | 22.4% (18.7 – 26.4%) | 0.754 |
Reports with ILN and follow-up recommendation | 75/108 | 69.4% (60.2 – 77.8%) | 80/101 | 79.2% (71.3 – 87.1%) | 0.107 |
Reports with ILN and follow-up recommendation using a macro* | 18/75 | 24.0% (14.7 – 33.3%) | 38/80 | 47.5% (36.3 – 58.8%) | 0.002 |
Reports with ILN and guideline concordant follow up recommendation | 53/75 | 70.7% (60.0 – 80.0%) | 60/80 | 75.0% (65.0 – 83.8%) | 0.544 |
ILN Warranting Both Low and High Risk Fleischner Society Recommendations | |||||
ILN in category warranting both low and high clinical risk recommendations (if/then statement) | 39/75 | 52.0% (41.3 – 62.7%) | 39/80 | 48.8% (37.5 – 60.0%) | 0.686 |
Report reflected guideline concordant recommendation | 18/39 | 46.2% (30.8 – 61.5%) | 24/39 | 61.5% (46.2 – 76.9%) | 0.173 |
ILN with Imaging Features Associated with Elevated Risk for Malignancy# | |||||
ILN with imaging features suggestive of elevated risk | 45/75 | 60.0% (49.3 – 70.7%) | 39/80 | 48.8% (37.5 – 60.0%) | 0.160 |
Report reflected guideline concordant recommendation | 37/45 | 82.2% (71.1 – 93.3%) | 30/39 | 76.9% (64.1 – 89.7%) | 0.547 |
ILN without Imaging Features Associated with Elevated Risk for Malignancy | |||||
ILN without imaging features suggestive of elevated risk | 30/75 | 40.0% (29.3 – 50.7%) | 41/80 | 51.3% (40.0 – 62.5%) | 0.160 |
Report reflected guideline concordant recommendation | 16/30 | 55.1% (36.7 – 70.0%) | 30/41 | 73.2% (58.5 – 85.4%) | 0.084 |
ILN = Incidental lung nodules
In 2014, individual radiologists may have used personal macros while in 2017 a department-wide standardized macro was implemented.
elevated risk features according to American College of Chest Physicians, Fleischner Society.